Vitamin treatment brings dramatic improvements

April 09, 2001

ST. PAUL, MN -- Researchers have discovered a new treatment for one form of the rare disorder hereditary ataxia that has resulted in remarkable improvements, according to a study in the April 10 issue of Neurology, the scientific journal of the American Academy of Neurology.

"An 8-year-old boy who was confined to a wheelchair was able to walk independently after the treatment, and a 20-year-old woman was able to work outside the home for the first time," said study author and neurologist Salvatore DiMauro, MD, of Columbia University in New York, NY.

Hereditary ataxia is a genetic neurological disorder that affects coordination. Patients have difficulty with balance, coordination of arms and legs and speech. Some patients also develop seizures. The disease often causes deterioration of the cerebellum, the area of the brain that controls coordination.

The researchers discovered that some patients with hereditary ataxia have a decreased level of coenzyme Q10, or CoQ10, in their muscles. CoQ10, also called ubiquinone, is a vitamin-like substance that plays a key role in the production of energy within cells. It is naturally present in small amounts in various foods.

For the study, the researchers identified people with hereditary ataxia with no known genetic cause. CoQ10 levels were low among the six patients identified -- about 70 percent lower than normal. The patients were then given daily supplements of CoQ10, ranging from 300 mg to 3,000 mg.

"All of the patients improved with the CoQ10," DiMauro said. "They got stronger, their ataxia improved and their seizures either stopped or happened less often.

One year after they started taking CoQ10, the patients' scores improved by an average of 25 percent on an ataxia scale measuring their balance, speech and movement. Five of the patients were unable to walk before receiving CoQ10; after treatment all were able to walk with some assistance, such as a rolling walker.

There are many forms of hereditary ataxia, also called hereditary spinocerebellar ataxia, or SCA. These patients did not have the autosomal dominant forms of SCA (SCA1 to SCA5) or Friedreich's ataxia.

"Our findings suggest that CoQ10 deficiency is a potentially important cause of some forms of familial ataxia and it should be considered when diagnosing this condition," DiMauro said. "Where low levels are found, treatment to replace the missing CoQ10 should be aggressive and begin early."

A neurologist is a medical doctor with specialized training in diagnosing, treating and managing disorders of the brain and nervous system.
-end-
The American Academy of Neurology, an association of more than 17,000 neurologists and neuroscience professionals, is dedicated to improving patient care through education and research.

For more information about the American Academy of Neurology, visit its web site at http://www.aan.com.

For more information contact: Kathy Stone, 651-695-2763 or kstone@aan.com

American Academy of Neurology

Related Brain Articles from Brightsurf:

Glioblastoma nanomedicine crosses into brain in mice, eradicates recurring brain cancer
A new synthetic protein nanoparticle capable of slipping past the nearly impermeable blood-brain barrier in mice could deliver cancer-killing drugs directly to malignant brain tumors, new research from the University of Michigan shows.

Children with asymptomatic brain bleeds as newborns show normal brain development at age 2
A study by UNC researchers finds that neurodevelopmental scores and gray matter volumes at age two years did not differ between children who had MRI-confirmed asymptomatic subdural hemorrhages when they were neonates, compared to children with no history of subdural hemorrhage.

New model of human brain 'conversations' could inform research on brain disease, cognition
A team of Indiana University neuroscientists has built a new model of human brain networks that sheds light on how the brain functions.

Human brain size gene triggers bigger brain in monkeys
Dresden and Japanese researchers show that a human-specific gene causes a larger neocortex in the common marmoset, a non-human primate.

Unique insight into development of the human brain: Model of the early embryonic brain
Stem cell researchers from the University of Copenhagen have designed a model of an early embryonic brain.

An optical brain-to-brain interface supports information exchange for locomotion control
Chinese researchers established an optical BtBI that supports rapid information transmission for precise locomotion control, thus providing a proof-of-principle demonstration of fast BtBI for real-time behavioral control.

Transplanting human nerve cells into a mouse brain reveals how they wire into brain circuits
A team of researchers led by Pierre Vanderhaeghen and Vincent Bonin (VIB-KU Leuven, Université libre de Bruxelles and NERF) showed how human nerve cells can develop at their own pace, and form highly precise connections with the surrounding mouse brain cells.

Brain scans reveal how the human brain compensates when one hemisphere is removed
Researchers studying six adults who had one of their brain hemispheres removed during childhood to reduce epileptic seizures found that the remaining half of the brain formed unusually strong connections between different functional brain networks, which potentially help the body to function as if the brain were intact.

Alcohol byproduct contributes to brain chemistry changes in specific brain regions
Study of mouse models provides clear implications for new targets to treat alcohol use disorder and fetal alcohol syndrome.

Scientists predict the areas of the brain to stimulate transitions between different brain states
Using a computer model of the brain, Gustavo Deco, director of the Center for Brain and Cognition, and Josephine Cruzat, a member of his team, together with a group of international collaborators, have developed an innovative method published in Proceedings of the National Academy of Sciences on Sept.

Read More: Brain News and Brain Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.